Activation Failure of Knee Extensors After Anterior Cruciate Ligament Rupture Depending on the Contraction Mode

NCT06783062 | Not Yet Recruiting DMC

• 1 other identifier: 2024-01580
• Study Type: observational
• Target: 60
• Locations: 0 countries
• Sites: N/A

Brief Summary

The primary objective of the study is to evaluate the impact of ACL injury and ACL reconstruction on voluntary activation during maximal voluntary contraction (measured by neurophysiological parameters) according to the contraction mode. The goal is to provide elements of knowledge to clinicians about the mechanisms of the activation failure depending on contraction mode, but also the resulting adapted clinical recommendations for conducting rehabilitation, and particularly for the use of different contraction modes. The main hypothesis is that activation failure is not equal according to the contraction mode during maximal voluntary contractions and neurophysiological parameters will be decreased in comparison with non-injured subjects. Secondary objectives are:

• To analyze the evolution of neurophysiological parameters between sessions interspaced by several months according to the contraction mode.
• To observe this time evolution depending on the treatment strategy chosen: rehabilitation or surgery plus rehabilitation.

Conditions

ACL - Anterior Cruciate Ligament Rupture; Activation Failure; Contraction Mode

Outcome Measures

Primary Outcomes (1)

• Voluntary Activation Level

  Between 2 and 6 weeks after ACL rupture

Secondary Outcomes (5)

• Maximal voluntary torque

  between 2 to 6 weeks after ACL rupture

• EMG activity of vastus lateralis, vastus medialis and rectus femoris

  between 2 to 6 weeks after ACL rupture

• Voluntary Activation Level

  Around 9 months after ACL rupture

• Maximal voluntary torque

  Around 9 months after ACL rupture

• EMG activity of vastus lateralis, vastus medialis and rectus femoris

  Around 9 months after ACL rupture

Study Arms (3)

Control

ACL - rehabilitation

ACL - surgery + rehabilitation

Eligibility Criteria

• Age: 18 Years - 50 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

The study population will comprise both male and female subjects, divided into three groups. The first group will consist of 20 subjects with isolated (only ACL rupture) or non-isolated ACL rupture (rupture associated with other knee lesion), treated with rehabilitation. The second group will include 20 subjects with ACL rupture, treated with surgery and rehabilitation. A third control group will also be included.

You may qualify if:

• A. ACL-injured groups (surgically or conservatively treated):
• Age between 18 and 50 years
• Free, informed consent signed by the participant and the investigator.
• Session 1: Delay of 2 to 6 weeks after injury, with a quiet knee (range of motion 110- 0°, minimal effusion, maximal contraction pain ≤ 2/10)
• Session 2: Duration of 36 to 42 weeks after injury, with a quiet knee (range of motion 110-0°, minimal effusion, maximal contraction pain ≤ 2/10)
• Independent person (Unprotected: under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision)
• B. ControlGroup:
• Age between 18 and 50 years
• Free, informed consent signed by the participant and the investigator.
• Sport practitioners: at least once per week practicing activities like collective sports, racket sports, combat sports, skiing, or on-loading activities with changing of directions.
• Independent person (Unprotected: under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision)

You may not qualify if:

• \. Subjects fitted with an implanted electronic device such as a cardiac pacemaker 2. Professional athlete 3. Pregnant women 4. Subject with systemic pathology or treatment affecting the musculoskeletal system 5. Subject with a history of neurological pathology or traumatic pathology, or pathology that required orthopedic treatment and/or surgery of the knee, hip and/or lumbar spine 6. Contraindication to isokinetic testing: incapacitating pain, evolving pathological process, non- healed fracture, unbalanced cardiovascular pathology (angina pectoris, arterial hypertension) 7. Contralateral knee injury 8. Subject inability to follow procedures or insufficient knowledge of project language 9. Data acquisition issue or injury during testing

Sponsors & Collaborators

• La Tour Hospital: lead
• Toulouse NeuroImaging Center (ToNIC - UMR 1214 Inserm/UPS): collaborator

MeSH Terms

Conditions

Anterior Cruciate Ligament Injuries

Condition Hierarchy (Ancestors)

Knee Injuries; Leg Injuries; Wounds and Injuries

Central Study Contacts

Simon Barrué-Belou, PhD

CONTACT

+41 22 719 78 92; simon.barruebelou@latour.ch

François Fourchet, PhD

CONTACT

francois.fourchet@latour.ch

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: PROSPECTIVE
• Target Duration: 9 Months
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Physiotherapist PhD., in charge of Biomechanics

Study Record Dates

• First Submitted: January 14, 2025
• First Posted: January 20, 2025
• Study Start: February 1, 2025
• Primary Completion (Estimated): December 1, 2027
• Study Completion (Estimated): December 1, 2027
• Last Updated: January 20, 2025

Record last verified: 2025-01